Deutsche Bank made a number of updates in a research report published today.
Valeant Pharmaceuticals (NYSE: VRX) had its rating reiterated at Buy. At the same time, its price target was raised from $62 to $64. On Friday, VRX added 4.54% to its value to finish the week at $55.
KapStone Paper (NYSE: KS) had its rating reiterated at Hold. On Friday, KS added 0.3% to its value to end the day at $16.50. Crown Holdings (NYSE: CCK) had its rating reiterated at Buy. On Friday, CCK added 0.95% to its value to end the day at $38.07. Louisiana-Pacific (NYSE: LPX) had its rating reiterated at Hold. On Friday, LPX lost 1.1% of its value to end the week at $8.1. Weyerhaeuser (NYSE: WY) had its rating reiterated at Sell. On Friday, WY added 0.42% to its value to finish the week at $21.65.
